Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Everolimus (RAD001) Therapy for Epilepsy in Patients With Tuberous Sclerosis Complex

NCT01070316 is registered in ClinicalTrials.gov with Children's Hospital Medical Center, Cincinnati as lead sponsor.

NCT NCT01070316
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01070316 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Everolimus (RAD001) Therapy for Epilepsy in Patients With Tuberous Sclerosis Complex
Lead sponsor
Children's Hospital Medical Center, Cincinnati
Phase
Phase 1/2
Overall status
Completed
Start date
January 31, 2010
Completion date
April 30, 2016
Enrollment
20 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy, tuberous sclerosis complex